Connective-tissue growth factor (CTGF) is a secreted protein implicated in multiple cellular events including angiogenesis, skeletogenesis and wound healing 
B
y sequence comparison to Chordin we noticed that CTGF contains a CR module previously designated as von Willebrand type c domain 7 (vwc). CTGF contains four distinct structural modules: an amino-terminal insulin-like growthfactor-binding domain (IGFB), followed by the CR/vwc domain, a thrombospondin type 1 repeat (TSP-1), and a carboxy-terminal cystine knot (CT) domain 8 ( Fig. 1a) . The same modular architecture is shared by the other CCN family members. A comparison of the CR domain of CTGF with the CR domains of von Willebrand factor (vWF), thrombospondin (TSP), procollagens I and II and chordin showed conservation of ten regularly spaced cysteines and a few additional amino-acid residues characteristic of CR domains 2 ( Fig. 1b) . Here we present functional studies on Xenopus laevis CTGF, a gene that is expressed in the floor plate, notochord, somites and other tissues known to be involved in early embryonic patterning (see Fig. S1 in the Supplementary Information).
Synthetic CTGF mRNA injected into a single ventral blastomere at the four-cell stage was able to induce secondary axes 9, 10 in Xenopus embryos (66%, n = 115, Fig. 2b ), which is consistent with inhibition of BMP signalling. The CTGF-induced axes were partial and never formed head structures with eyes, but included somites marked by the muscle-specific marker antibody 12- GenBank accession numbers  XP037056, NM000552, P35448, NP001835, P02452 and AAC42222, respectively). Black boxes represent identical amino acids and gray boxes similar amino acids; dashes indicate gaps introduced to optimize the alignment. Asterisks mark the ten identical cysteine residues characteristic of CR domains.
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( Fig. 2e ). In addition, CTGF caused a weaker induction of the panneural marker N-CAM and downregulation of the epidermal markers Msx-1 and Cytokeratin (Fig. 2e) . Microinjection of CTGF mRNA into the animal pole resulted in embryos with enlarged heads, shortened trunk and tail structures (Fig. 2f, g ), and expanded expression of the anterior cement-gland marker XAG-1 (Fig. 2h, i) . In CTGF-injected embryos analysed at the neurula stage, the expression domain of the neural-plate marker Sox-2 was expanded (Fig. j, k) and, reciprocally, the expression domain of Msx-1, which demarcates the border between the neural plate and epidermis, was displaced laterally (Fig. 2m, n) . Embryos injected with CTGF-CR also developed with expanded neural plates (Fig. 2l, o) . We conclude from these in vivo results that CTGF can induce anti-BMP phenotypes in microinjected Xenopus embryos through its CR domain. To test whether CTGF and BMP interacted biochemically, Flagepitope-tagged constructs of full-length CTGF, CTGF-CR, CTGF-∆CR and the C terminus of CTGF (CTGF-CT) were generated and the proteins produced in cultured cells (Fig. S2) . To produce CTGF in sufficient amounts for biochemical experiments we generated a Drosophila melanogaster S2 stable cell line secreting Flag-tagged Xenopus CTGF. Under these conditions the protein was full length and could be affinity-purified via its Flag tag (Fig. S2) . Immunoprecipitation assays showed that full-length CTGF, like the positive control chordin, could bind BMP4 in solution (Fig. 3a,  lanes 2, 3) . Using a monoclonal antibody that is entirely specific for BMP4 (ref. 11), we showed in western blots that the binding of BMP4 to CTGF could be competed by an excess of BMP2 or TGF-β1 but not by IGF-1 (Fig. 3b, lanes 2-5) . The interaction between CTGF and BMP4 was direct, because in chemical crosslinking experiments, full-length CTGF or the CR domain of CTGF (CTGF-CR) could be crosslinked to BMP4, forming complexes of the expected molecular weights (Fig. 3c, lanes 2, 5) . Conversely, CTGF constructs lacking the CR domain (CTGF-∆CR and CTGF-CT) were unable to form complexes with BMP4 (Fig. 3c, lanes 3, 4) . The observation that binding of BMP4 to CTGF could be partially competed by TGF-β1 (Fig. 3b, lane 4) suggested that CTGF might also bind TGF-β1. Chemical crosslinking experiments showed that TGF-β1 could also bind directly to CTGF or to CTGF-CR (Fig. 3d,  e) . The binding affinity of CTGF for BMP4 and TGF-β1 was determined by surface plasmon resonance (SPR) analysis, a method used previously to evaluate real-time interactions between BMP and follistatin 12 . Kinetic measurements using different concentrations of CTGF yielded dissociation constants (K D ) of 5 nM for BMP4 and of 30 nM for TGF-β1 (Fig. 3f) . We conclude from these biochemical studies that CTGF can directly bind BMP4 and TGF-β1 through its CR domain, and has a higher affinity for BMP4 than for TGF-β1.
Purified CTGF inhibited BMP signalling in 10T1/2 cells 13, 14 ( Fig. 4a, b ). Increasing amounts of CTGF inhibited the alkaline phosphatase (AP) activity induced by 2.5 nM BMP4 in a dosedependent manner ( Fig. 4b ) with 50% inhibition (IC 50 ) at approximately 12 nM. The phosphorylation of Smad1 induced by 0.5 nM BMP4 was inhibited by the addition of 20 nM CTGF (Fig. 4c , lanes 2 and 3) to human 293T cell cultures 15 . Interestingly, an excess of BMP4 (10 nM) was able to quench the antagonistic effect of CTGF on BMP4 action (Fig. 4c, lanes 4 and 5) . To address the molecular mechanism by which CTGF inhibited BMP4 signalling we next examined the effect of CTGF on the binding of BMP4 to its cognate receptor 16 . Increasing amounts of CTGF antagonized BMP4 binding to a recombinant type Ia BMP-receptor-Fc fusion protein, as shown by western blot analysis with anti-BMP4 antibody (Fig. 4d,  lanes 2-5) . We conclude that binding of BMP4 to CTGF inhibits BMP signalling by preventing the binding of BMP4 to its cognate receptor. This molecular mechanism of action is analogous to that of the BMP antagonist chordin 17 , it was found that crosslinking of TGF-β to all three TGF-β interacting proteinsbetaglycan, TβRII and TβRI -increased in the presence of CTGF (Fig. 5b) . Because CTGF binds TGF-β1 with relatively low affinity (with a K D value of only 30 nM, Fig. 3f ), it is conceivable that CTGF may function as a chaperone to modify the conformation or solubility of TGF-β1 and facilitate presentation to its cognate receptors, which have affinities in the picomolar range 17 . Signalling by TGF-β1 was also increased by CTGF. At low TGF-β1 concentrations, CTGF potentiated the phosphorylation of Smad2 induced by TGF-β1 (Fig. 5c , lanes 2 and 3) in fetal mink lung (Mv1Lu) cell cultures. At higher concentrations of TGF-β1, CTGF did not increase Smad2 phosphorylation, indicating that CTGF serves to potentiate the effects of limiting amounts of TGF-β1 and has no detectable effects of its own on these cells (Fig. 5c , lanes 4-6). In addition, a TGF-β reporter gene 18 was induced 6-10-fold by as little as 3 nM CTGF (Fig 5d) . TGF-β1 was required, as CTGF alone did not induce reporter-gene expression, even at 45 nM (Fig. 5d ). 
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Uninj. The synergy between CTGF and TGF-β1 was accompanied by a striking and unexpected morphological change in the cultures. Spherical aggregates of cells were observed in Mv1Lu cells treated with TGF-β1 and purified CTGF, but not when treated with either factor on its own ( Fig. 5e and Fig. S3 in the Supplementary Information). These effects of CTGF were not caused by a blockade of endogenous BMP signals, because addition of 10 nM chordin or BMPRIa-Fc (which are sufficient to inhibit BMP4 signalling in cell culture, data not shown) together with TGF-β1 did not induce spherical structures in Mv1Lu cells (Fig. 5e ). In embryonal carcinoma P19 cells similar structures were induced by CTGF alone (Fig. 5f ), presumably because these cells produce endogenous TGF-β (see the legend to Fig. S3 ). The cell aggregates were positive for platelet-endothelial cell-adhesion molecule (PECAM-1) and for vWF ( Fig. 5f and Fig. S3 ). Although these molecules are markers for endothelial cells, it has recently been reported that PECAM-1 is not entirely specific for blood vessels 19 and therefore the determination of whether the spherical structures reported here correspond to blood-vessel-like structures must await further experimentation. We conclude that CTGF protein enhances TGF-β1 signalling by several criteria, including receptor and cell-surface binding, Smad2 phosphorylation, activation of gene expression, and differentiation of cultured cell lines.
Although multiple physiological roles have been proposed for CTGF, its signalling pathway remains unknown. CTGF can bind to low-density lipoprotein receptor-related protein and integrins 20, 21 , but the consequences of these interactions on downstream signaltransduction pathways are not known. The results reported here indicate that CTGF signals in part through the binding of BMP4/2 and TGF-β1 in the extracellular space. We find that CTGF inhibits BMP but activates TGF-β1 signalling. TGF-β is a well-known inducer of extracellular matrix (ECM) components such as collagen and fibronectin 22, 23 . The CTGF gene may participate in this event, as its promoter contains a TGF-β response element 24, 25 . In support of this view, collagen deposition and anchorage-independent growth induced by TGF-β in fibroblasts can be inhibited by adding neutralizing antibodies against CTGF 23, 26 , indicating a synergistic relationship between CTGF and TGF-β. The function of the other domains in CTGF remains to be investigated: the IGFB domain has been shown to bind IGF although this interaction is of low affinity (ref. 27 and our unpublished observations), TSP-1 domains have been implicated in extracellular matrix and vascular endothelial growth factor (VEGF) binding 28, 29 , and the cystine-knot module may contribute a dimerization motif or additional signalling capabilities 30 . In conclusion, the results presented here suggest a molecular mechanism for CTGF function by which this protein can activate TGF-β signalling and inhibit BMP activity by directly binding to these growth factors in the extracellular space through its Chordin-like domain. +  +  +  BMP4  -+  +  +  +  CTGF  --+  --BMP2  ---+  -TGF-β1  ----+  IGF-1   1  2  3  4  5  1 
Methods

DNA constructs and embryo manipulations
The complete open reading frame of Xenopus CTGF was amplified by PCR from cDNA of stage 25 embryos using the following primers: forward 5′-AAA CTC GAG GAA CTA ATC TGC TGC TGT-3′ and reverse 5′-AAA TCT AGA TGT GTT TCT CTG CCT CTA-3′, based on the sequence from GenBank accession number U43523 entered by M. L. King and Z. Ying in 1997. The PCR product was cloned in the expression vector pCS2 + . Epitope-tag subclones were generated by amplifying CTGF lacking the signal peptide and inserting the fragment in-frame into pCS2 + containing a chordin signal peptide until Ala41, followed by the Flag-tag sequence (pchd-Flag). The primers used for Flag-tagged fulllength CTGF or deletion mutants were as follows: CTGF 5′-AAA CTC GAG CAG GAG TGT AAT GGG GAA T-3′ and 5′-AAA TCT AGA TGT GTT TCT CTG CCT CTA-3′; CTGF-CR 5′-AAA CTC GAG GCC CCT TGT TGT GTT CGG-3′ and 5′-AAA TCT AGA TAG CGC GGA TTA GGG ATG GA-3′; CTGF-CT, 5′-AAA CTC GAG GGT CCT GAT CCA TCC CTA-3′ and T7 primer. CTGF-∆CR was generated by deletion of sequences between Ala95 and Ala191 of CTGF by PCR mutagenesis. Detailed protocols for embryo fertilizations, in situ hybridization and RT-PCR can be found at http://www.hhmi.ucla.edu/derobertis/index.html.
Protein purification, immunoprecipitation and crosslinking
Flag-tagged secreted proteins were obtained by transient tranfection of human 293T cells or from Drosophila S2 cells stably expressing CTGF (Fig. S2) . Full-length Flag-CTGF from S2 cells was affinitypurified with anti-Flag M2 affinity gel column and eluted with Flag peptide according to manufacturer's directions (Sigma, St Louis, MO). Culture medium obtained from Drosophila S2 cells transfected with empty vector was purified in the same way and used as negative control in all experiments. Protein concentrations were determined using bovine serum albumen (BSA) standards stained with Coommassie blue in SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Immunoprecipitation analyses and chemical crosslinking with disuccinimidyl suberate (DSS) were performed as described previously 4, 13 . , sedimented by centrifugation and the pellets solubilized with solubilization buffer (125 mM NaCl, 10 mM Tris, 1 mM EDTA, pH 7.0, 1% Triton X-100). Cell debris were removed by centrifugation, and samples were subjected to SDS-PAGE.
TGF-β-receptor binding
Surface plasmon resonance (SPR) analysis
Real-time binding experiments were performed on the Biacore 2000 apparatus (Biacore AB, Uppsala, Sweden) as described previously 12 . Carrier-free recombinant human BMP4 and TGF-β1 from human platelets (R&D Systems) were immobilized on the sensor-chip surface (CM5, certified grade, Biacore AB). HBS-EP buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA and 0.005% v/v surfactant P20) was used as running buffer.
Cell culture assays and immunocytochemistry
Alkaline phosphatase (AP) induction assay 13 was performed in the multipotent mesodermal cell line 10T1/2 (ATCC) using the fluorescent substrate 4-methyl umbelliferyl-phosphate (Sigma). AP values were normalized using the amount of protein in each tissue-culture well (Bio-Rad Dc protein kit). Mink lung epithelial cells (Mv1Lu -CCL 64, ATCC) were cultured in alpha-minimal essential media (MEM; Gibco, Grand Island, NY) supplemented with 10% foetal bovine serum. Cells plated in 96-well plates were transiently co-transfected with 0.1 µg of p3TP-lux (ref. 18) and 0.015 µg of pBSKSβ-gal expression plasmid using FuGENE (Roche, Indianapolis, IN) as a transfection reagent. Before growth factors were added, cells were washed with phosphate buffer saline and pre-incubated for 2 h with alpha-MEM containing 2% NuSerum (BD Biosciences, San Jose, CA). Growth factors diluted in alpha-MEM containing 2% NuSerum were pre-incubated at room temperature for 1 h before they were added to cells. After 18 h cells were lysed in Reporter Lysis Buffer (Promega, Madison, WI), and enzyme activity measured using the Luciferase Assay System and the β-Galactosidase Enzyme Assay System (Promega). Enzyme activities were measured in a microplate luminometer and enzyme-linked immunosorbent assay (ELISA) plate reader, respectively. Smad phosphorylation was detected on western blots using 1:6000 dilution of anti-phosphoSmad1 (specific for Smad 1, 5 and 8, gift of C. H. Heldin), 1:500 dilution of anti-phosphoSmad2 (Upstate Biotechnology, Waltham, MA), and 1:400 actin antibodies (Sigma) for protein loading controls. Purified growth factors were premixed for 1 h in serum-free medium (DMEM, F12, Iscove's, 1:1:1) at room temperature, and added to 80% confluent 293T or Mv1Lu cells for 2 h. Immunocytochemistry was performed with an endothelial-specific anti-CD31 (PECAM-1) monoclonal antibody 22 125 I-TGF-β1 (100 pM) was pre-incubated 1 h with (+) or without (−) 6 nM CTGF before adding for receptor binding 17 . Specific binding was shown by competition with 50-fold unlabelled TGF-β1 (lane 3). Lane 4 shows negative control crosslinking of CTGF, and [I 125 ]-TGF-β1 in the absence of cells. The three major cell surface TGF-β receptors 17 are indicated: betaglycan (βG, 250 kDa), TGF-β-receptor II (TβRII, 80 kDa) and TGF-β-receptor I (TβRI, 68 kDa). c, Two hours after addition of proteins, Smad2 phosphorylation in Mv1Lu cells was stimulated by 6 nM CTGF in the presence of 10 pM TGF-β1. This effect was not seen when TGF-β1 was increased fivefold. Lane 6 shows that CTGF has no effect on its own. Note that Smad2 phosphorylation was induced at lower concentrations of TGF-β1 than those required in reporter-gene or cell-differentiation assays (see below), perhaps reflecting the shorter treatment times involved. . Supernatant was collected, centrifuged and western blot using anti-Flag antibody performed. Note that the proteins produced in Xenopus were not cleaved. d, e, Large scale production and purification of fulllength CTGF. Expression of Flag-CTGF in Drosophila S2 cells was performed as described 3 . Briefly, Flag-CTGF was sub-cloned into pUAST vector. To establish a cell line 5 βg of pUAST-CTGF were co-transfected with 1 βg of pCoHygro (Invitrogen, for hygromycin resistance) and 5 βg of pGal/pRmHa3, which contains the yeast Gal-4 protein under the control of the methalothioneine promoter. FuGENE (Roche) was used as transfection reagent and cells were selected with 250 βg/ml of Hygromycin for 60 days. For protein secretion, 500 µM of CuSO 4 was added to induce Gal4, which in turn induced CTGF expression via its UAS promoter. Note that the flag-CTGF produced by S2 cells is full-length. e, Flag-CTGF in S2 cell secreted media was purified by anti-Flag affinity gel (Sigma) column and eluted with Flag peptide (Sigma). Fractions were analyzed by SDS-PAGE stained with Coomassie blue. The gel was loaded with aliquots of the input in the column (I), of the flow through (FT), of the first and third washes (W1, W3) and of the three elutions (E1, E2 and E3). This method yielded approximately 100 βg of pure CTGF per 30 ml of tissue culture medium. We found that the use of full-length affinity-purified CTGF was essential for the crosslinking, binding analysis and cell culture results shown here. The use of Drosophila S2 cells was crucial as human 293T cells secrete large amounts of proteolytically processed CTGF. It is not known whether this proteolytic cleavage, which occurs close to the center of the protein, has a biological role on CTGF function in vivo. [1] [2] [3] [4] . Immunocytochemistry was performed with the cell surface antigen [5] [6] CD31, also known as platelet-endothelial cell adhesion molecule or PECAM-1. As shown in panel a, it was found that, indeed, the spherical aggregates were PECAM-1 positive. Spherical aggregates of PECAM-1-positive cells were not observed in Mv1Lu cells treated with TGF-β1 or CTGF alone. Interestingly, in the pluripotent mouse embryonal carcinoma P19 cell line, addition of CTGF induced PECAM-1 positive cell aggregates without requiring the addition of TGF-β1 (Fig. 5f) . The mouse P19 cell structures were positive for PECAM-1 and for von Willebrand Factor, another endothelial marker (Fig. 5f ). Panel b shows that increased amounts of vWF protein were detected in Mv1Lu cells treated with CTGF and TGF-β1 by Western blot (lane 6); polyclonal anti-vWF (Dako Co) was used at 1:200, and purified vWF and mouse placental proteins were used as positive controls. Spherical structures are induced by CTGF alone in P19 cells (see Fig. 5f of main text) presumably because they express endogenous TGF-β1 signals, since P19 cells have higher basal luciferase levels than Mv1Lu cells when transfected with a TGF-β-inducible reporter (data not shown). Mv1Lu cells have been very useful in TGF-β research because they have an intact TGF-β signal transduction pathway 7 yet express low levels of endogenous TGF-β signals, which strongly inhibit their proliferation 8 . Further experiments will be required to determine whether Mv1Lu cells, which were established from fetal mink lung tissue, are of endothelial origin. If the aggregates induced in Mv1Lu cells treated with CTGF and TGF-β1 eventually are proven to form blood vessel-like spherical structures, they will provide a valuable system for the molecular dissection of the signals involved in angiogenesis. The CTGF gene has been inactivated by homologous recombination in the mouse and defects in angiogenesis are apparent in regions where CTGF and TGF-β are normally co-expressed, identifying CTGF as an essential mediator of angiogenesis in vivo (S. Ivkovic and K. M. Lyons personal communication). In gain-of-function experiments, CTGF ectopically expressed in chicken chorioallantoic membranes or in the rat cornea has been shown to promote angiogenesis and neovascularization 3, 4 . Even if it is eventually demonstrated that these remarkable structures are not of vascular nature, the formation of these cell aggregates may still provide an interesting in vitro system for the study of mesenchymal to epithelial transformation under the control of extracellular signals.
